Adherium Ltd. (ASK:ADR) said today that it won 510(k) approval from the FDA for its inhaler monitoring device, SmartTouch for Symbicort. The device was cleared for use with AstraZeneca‘s (NYSE:AZN) Symbicort aerosol inhaler.
The Melbourne, Australia-based company’s product installs directly onto a patient’s inhaler to monitor and boost medication adherence.
Get the full story at our sister site, Drug Delivery Business News.
The post Adherium wins 510(k) clearance for smart inhaler monitoring device appeared first on MassDevice.